Latest market price
4.00
-0.21-4.99%
OverviewShort InterestFilings
ABUSQT52Arbutus Biopharma Corp·NASDAQ
4.00-4.99%

Latest SEC Filings

Form category
DescriptionFilingDocument
Oct 27, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 22, 20268-KCurrent report
Oct 07, 20264Statement of changes in beneficial ownership
Oct 07, 20264Statement of changes in beneficial ownership
Oct 07, 20264Statement of changes in beneficial ownership
Oct 07, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Oct 07, 20264Statement of changes in beneficial ownership
Oct 05, 2026SC 13D/ABeneficial ownership statement (active, amended)
Oct 05, 20264Statement of changes in beneficial ownership
Oct 01, 2026SC TO-I/ASC TO-I/A
Sep 30, 2026SC TO-I/ASC TO-I/A
Sep 23, 20264Statement of changes in beneficial ownership
Sep 23, 20264Statement of changes in beneficial ownership
Sep 23, 20264Statement of changes in beneficial ownership
Sep 23, 20264Statement of changes in beneficial ownership
Sep 04, 2026SC 13GBeneficial ownership statement (passive)
Aug 24, 2026SC TO-IIssuer tender offer statement
Aug 21, 2026SC TO-CSC TO-C
Aug 21, 20268-KCurrent report
Aug 12, 202610-QQuarterly report
Aug 12, 20268-KCurrent report
Aug 12, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 16, 20268-KCurrent report
Jun 10, 20264Statement of changes in beneficial ownership
Jun 10, 20264Statement of changes in beneficial ownership
#1 / 25 of 255
Page
▼
/ 11